Clinical Trial Update: Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus [Phase 1]

View source ↗

Summary

Sanofi completed a Phase 1 single-dose clamp study comparing two new insulin glargine formulations with Lantus to evaluate concentration/time and metabolic acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine Formulation A (insulin glargine)
• Insulin Glargine Formulation B (insulin glargine)
• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED